Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?

Autores
Goffin, Vincent; Becu, Damasia; Popovic, Vera; Grattan, David R.
Año de publicación
2023
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Prolactin is an anterior pituitary hormone that was originally named for its indispensable role in lactation, but increasingly it is being recognized for pleiotropic roles in metabolism, immune function, pregnancy adaptations and parental behaviour. Prolactin secretion is tightly controlled by a short-loop feedback system whereby prolactin stimulates specific neurons in the hypothalamus to release dopamine, which then inhibits prolactin secretion. During pregnancy and lactation, however, this feedback systems adapts to allow prolonged elevations in prolactin secretion, enabling a range of functions specific to these conditions. Prolactin is also released under conditions of stress in both sexes. Prolactin signals exclusively through the prolactin receptor (Prlr), but this is not a simple system. In target cells, prolactin/Prlr engages various signal transduction mechanisms including JAK2/STAT5 (canonical), PI3K/Akt, MAPK and Src family kinases. There is also evidence of local production of prolactin in non-pituitary tissues, leading to autocrine/paracrine receptor triggering independent of circulating hormone. Adding to this complexity, in many species, including humans, there are multiple ligands for the Prlr. These include placental lactogens that supplement prolactin function in pregnancy, and in primates only, pituitary growth hormone. Moreover, specific proteolytic products of these hormones exert important biological actions independent of Prlr. These functions, that are often completely distinct from those of prolactin, have led to the classification of these fragments as a new class of hormones known as vasoinhibins.
Fil: Goffin, Vincent. Universite de Paris V; Francia. Inserm; Francia
Fil: Becu, Damasia. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Popovic, Vera. University of Belgrade; Serbia
Fil: Grattan, David R.. University of Otago; Nueva Zelanda
Materia
PROLACTIN
METABOLISM
CANCER
ADIPOSE TISSUE
THERAPY
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/243789

id CONICETDig_7e6bbabf5c7cd4156a364f7425fa116c
oai_identifier_str oai:ri.conicet.gov.ar:11336/243789
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?Goffin, VincentBecu, DamasiaPopovic, VeraGrattan, David R.PROLACTINMETABOLISMCANCERADIPOSE TISSUETHERAPYhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Prolactin is an anterior pituitary hormone that was originally named for its indispensable role in lactation, but increasingly it is being recognized for pleiotropic roles in metabolism, immune function, pregnancy adaptations and parental behaviour. Prolactin secretion is tightly controlled by a short-loop feedback system whereby prolactin stimulates specific neurons in the hypothalamus to release dopamine, which then inhibits prolactin secretion. During pregnancy and lactation, however, this feedback systems adapts to allow prolonged elevations in prolactin secretion, enabling a range of functions specific to these conditions. Prolactin is also released under conditions of stress in both sexes. Prolactin signals exclusively through the prolactin receptor (Prlr), but this is not a simple system. In target cells, prolactin/Prlr engages various signal transduction mechanisms including JAK2/STAT5 (canonical), PI3K/Akt, MAPK and Src family kinases. There is also evidence of local production of prolactin in non-pituitary tissues, leading to autocrine/paracrine receptor triggering independent of circulating hormone. Adding to this complexity, in many species, including humans, there are multiple ligands for the Prlr. These include placental lactogens that supplement prolactin function in pregnancy, and in primates only, pituitary growth hormone. Moreover, specific proteolytic products of these hormones exert important biological actions independent of Prlr. These functions, that are often completely distinct from those of prolactin, have led to the classification of these fragments as a new class of hormones known as vasoinhibins.Fil: Goffin, Vincent. Universite de Paris V; Francia. Inserm; FranciaFil: Becu, Damasia. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Popovic, Vera. University of Belgrade; SerbiaFil: Grattan, David R.. University of Otago; Nueva ZelandaFrontiers Media2023-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/243789Goffin, Vincent; Becu, Damasia; Popovic, Vera; Grattan, David R.; Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?; Frontiers Media; Frontiers in Endocrinology; 14; 6-2023; 1-21664-2392CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1213895/fullinfo:eu-repo/semantics/altIdentifier/doi/10.3389/fendo.2023.1213895info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:42:08Zoai:ri.conicet.gov.ar:11336/243789instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:42:08.477CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?
title Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?
spellingShingle Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?
Goffin, Vincent
PROLACTIN
METABOLISM
CANCER
ADIPOSE TISSUE
THERAPY
title_short Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?
title_full Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?
title_fullStr Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?
title_full_unstemmed Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?
title_sort Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?
dc.creator.none.fl_str_mv Goffin, Vincent
Becu, Damasia
Popovic, Vera
Grattan, David R.
author Goffin, Vincent
author_facet Goffin, Vincent
Becu, Damasia
Popovic, Vera
Grattan, David R.
author_role author
author2 Becu, Damasia
Popovic, Vera
Grattan, David R.
author2_role author
author
author
dc.subject.none.fl_str_mv PROLACTIN
METABOLISM
CANCER
ADIPOSE TISSUE
THERAPY
topic PROLACTIN
METABOLISM
CANCER
ADIPOSE TISSUE
THERAPY
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Prolactin is an anterior pituitary hormone that was originally named for its indispensable role in lactation, but increasingly it is being recognized for pleiotropic roles in metabolism, immune function, pregnancy adaptations and parental behaviour. Prolactin secretion is tightly controlled by a short-loop feedback system whereby prolactin stimulates specific neurons in the hypothalamus to release dopamine, which then inhibits prolactin secretion. During pregnancy and lactation, however, this feedback systems adapts to allow prolonged elevations in prolactin secretion, enabling a range of functions specific to these conditions. Prolactin is also released under conditions of stress in both sexes. Prolactin signals exclusively through the prolactin receptor (Prlr), but this is not a simple system. In target cells, prolactin/Prlr engages various signal transduction mechanisms including JAK2/STAT5 (canonical), PI3K/Akt, MAPK and Src family kinases. There is also evidence of local production of prolactin in non-pituitary tissues, leading to autocrine/paracrine receptor triggering independent of circulating hormone. Adding to this complexity, in many species, including humans, there are multiple ligands for the Prlr. These include placental lactogens that supplement prolactin function in pregnancy, and in primates only, pituitary growth hormone. Moreover, specific proteolytic products of these hormones exert important biological actions independent of Prlr. These functions, that are often completely distinct from those of prolactin, have led to the classification of these fragments as a new class of hormones known as vasoinhibins.
Fil: Goffin, Vincent. Universite de Paris V; Francia. Inserm; Francia
Fil: Becu, Damasia. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Popovic, Vera. University of Belgrade; Serbia
Fil: Grattan, David R.. University of Otago; Nueva Zelanda
description Prolactin is an anterior pituitary hormone that was originally named for its indispensable role in lactation, but increasingly it is being recognized for pleiotropic roles in metabolism, immune function, pregnancy adaptations and parental behaviour. Prolactin secretion is tightly controlled by a short-loop feedback system whereby prolactin stimulates specific neurons in the hypothalamus to release dopamine, which then inhibits prolactin secretion. During pregnancy and lactation, however, this feedback systems adapts to allow prolonged elevations in prolactin secretion, enabling a range of functions specific to these conditions. Prolactin is also released under conditions of stress in both sexes. Prolactin signals exclusively through the prolactin receptor (Prlr), but this is not a simple system. In target cells, prolactin/Prlr engages various signal transduction mechanisms including JAK2/STAT5 (canonical), PI3K/Akt, MAPK and Src family kinases. There is also evidence of local production of prolactin in non-pituitary tissues, leading to autocrine/paracrine receptor triggering independent of circulating hormone. Adding to this complexity, in many species, including humans, there are multiple ligands for the Prlr. These include placental lactogens that supplement prolactin function in pregnancy, and in primates only, pituitary growth hormone. Moreover, specific proteolytic products of these hormones exert important biological actions independent of Prlr. These functions, that are often completely distinct from those of prolactin, have led to the classification of these fragments as a new class of hormones known as vasoinhibins.
publishDate 2023
dc.date.none.fl_str_mv 2023-06
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/243789
Goffin, Vincent; Becu, Damasia; Popovic, Vera; Grattan, David R.; Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?; Frontiers Media; Frontiers in Endocrinology; 14; 6-2023; 1-2
1664-2392
CONICET Digital
CONICET
url http://hdl.handle.net/11336/243789
identifier_str_mv Goffin, Vincent; Becu, Damasia; Popovic, Vera; Grattan, David R.; Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?; Frontiers Media; Frontiers in Endocrinology; 14; 6-2023; 1-2
1664-2392
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1213895/full
info:eu-repo/semantics/altIdentifier/doi/10.3389/fendo.2023.1213895
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Frontiers Media
publisher.none.fl_str_mv Frontiers Media
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844614453640822784
score 13.070432